Comparison of Phacoemulsification and Corneal Damage Between FLACS and Standard Phaco With Two Handpieces
Corneal Endothelial Cell Loss, Cataract, Astigmatism
About this trial
This is an interventional treatment trial for Corneal Endothelial Cell Loss focused on measuring Corneal Endothelial Cell Loss, Centurion Vision System, Infiniti Vision System, cumulative dissipated energy, Phacoemulsification, Active Sentry handpiece, Laser Therapy, Ozil handpiece
Eligibility Criteria
Inclusion Criteria:
- Adult patient (over 18 years of age)
- Patients undergoing uncomplicated cataract surgery with intraocular lens implantation
- Ability to provide informed consent;
- Ability to be followed for the entire duration of the study.
Exclusion Criteria:
- Minor patient (under 18 years of age)
- Unable to give informed consent
- Unable to be followed for the duration of the study
- Another surgery combined with cataract extraction
- History of ocular surgery
- Patient with concomitant ocular diseases other than cataract (such as corneal, retinal, or glaucoma diseases)
- Irregular corneal astigmatism or keratoconus
Sites / Locations
- Centre Hospitalier de l'Université de MontréalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
Femtosecond laser assisted cataract surgery with Active Sentry handpiece
Standard phacoemulsification with the Active Sentry handpiece
Standard phacoemulsification with the OZil handpiece
Participants suffering from cataract who are candidates for femtosecond laser assisted cataract surgery
Participants suffering from cataract who are candidates for standard phacoemulsification with the new Active Sentry handpiece
Participants suffering from cataract who are candidates for standard phacoemulsification with the traditional OZil handpiece